Efficacy and safety analysis of different dose idarubicin plus cytarabine regimen as induction chemotherapy for young patients with de-novo acute myeloid leukemia

被引：0
|
作者：
张仪 [1 ]
机构：
[1] 1st Affil Hosp,Zhejiang Univ
来源：
China Medical Abstracts(Internal Medicine) | 2016年 / 33卷 / 04期
关键词：
AML; IA; were; Efficacy and safety analysis of different dose idarubicin plus cytarabine regimen as induction chemotherapy for young patients with de-novo acute myeloid leukemia; for; of; with;
D O I：
暂无
中图分类号：
R733.71 [急性白血病];
学科分类号：
100214 ;
摘要：
Objective To compare the efficacy,safety and longterm prognosis between different dose idarubicin(IDA)combined with cytarabine(IA)as induction chemotherapy in newly diagnosed young patients of acute myeloid leukemia(AML).Methods A total of 149 newly diagnosed young AML patients(APL excluded)between January 2009 to July 2014 was enrolled.According to the
引用
收藏
页码：231 / 231
页数：1
相关论文
共 50 条
  • [1] Intensified Induction Chemotherapy with Regimen Containing Intermediate Dose Cytarabine for De Novo Acute Myeloid Leukemia
    Wang, Jianxiang
    Mi, Yingchang
    Liu, Jiazhuo
    Fu, Mingwei
    Wang, Ying
    Lin, Dong
    Bian, Shougeng
    BLOOD, 2008, 112 (11) : 348 - 348
  • [2] Efficacy and safety of the HAA regimen as induction chemotherapy in 236 de novo acute myeloid leukemia
    叶佩佩
    China Medical Abstracts(Internal Medicine), 2013, 30 (04) : 232 - 232
  • [3] Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia
    Liu, Jiazhuo
    Mi, Yingchang
    Fu, Mingwei
    Yu, Wenjuan
    Wang, Ying
    Lin, Dong
    Bian, Shougeng
    Wang, Jianxiang
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (07) : 422 - 427
  • [4] Low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia
    Jin, Jie
    Chen, Jian
    Suo, Shanshan
    Qian, Wenbin
    Meng, Haitao
    Mai, Wenyuan
    Tong, Hongyan
    Huang, Jian
    Yu, Wenjuan
    Wei, Juyin
    Lou, Yinjun
    LEUKEMIA & LYMPHOMA, 2015, 56 (06) : 1691 - 1697
  • [5] Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia
    Duan, Wenbing
    Yang, Sen
    Zhao, Ting
    Hu, Lijuan
    Qin, Yazhen
    Jia, Jinsong
    Wang, Jing
    Lu, Shengye
    Jiang, Hao
    Zhang, Xiaohui
    Xu, Lanping
    Wang, Yu
    Lai, Yueyun
    Shi, Hongxia
    Huang, Xiaojun
    Jiang, Qian
    ANNALS OF HEMATOLOGY, 2023, 102 (10) : 2695 - 2705
  • [6] Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia
    Wenbing Duan
    Sen Yang
    Ting Zhao
    Lijuan Hu
    Yazhen Qin
    Jinsong Jia
    Jing Wang
    Shengye Lu
    Hao Jiang
    Xiaohui Zhang
    Lanping Xu
    Yu Wang
    Yueyun Lai
    Hongxia Shi
    Xiaojun Huang
    Qian Jiang
    Annals of Hematology, 2023, 102 : 2695 - 2705
  • [7] Venetoclax plus cyclophosphamide and cytarabine as induction regimen for adult acute myeloid leukemia
    Zhang, Baohang
    Liu, Qingguo
    Li, Junfan
    Hu, Yimin
    Zhao, Xin
    Huang, Pingping
    Li, Shangzhu
    Wang, Ying
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [8] Efficacy and Toxicity of Induction Therapy with Cladribine, Idarubicin, and Cytarabine (IAC) for Acute Myeloid Leukemia
    Woelich, Susan K.
    Braun, James T.
    Schoen, Martin W.
    Ramlal, Reshma
    Freter, Carl E.
    Petruska, Paul J.
    Lionberger, Jack M.
    ANTICANCER RESEARCH, 2017, 37 (02) : 713 - 717
  • [9] HIGH-DOSE CYTARABINE, IDARUBICIN, AND GRANULOCYTE-COLONY-STIMULATING FACTOR REMISSION INDUCTION THERAPY FOR PREVIOUSLY UNTREATED DE-NOVO AND SECONDARY ADULT ACUTE MYELOID-LEUKEMIA
    BAER, MR
    CHRISTIANSEN, NP
    FRANKEL, SR
    BRUNETTO, VL
    MROZEK, K
    BLOOMFIELD, CD
    HERZIG, GP
    SEMINARS IN ONCOLOGY, 1993, 20 (06) : 6 - 12
  • [10] Comparison of Reduced-Intensity Idarubicin and Daunorubicin Plus Cytarabine as Induction Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia
    Hui Liu
    Rong Fu
    Lijuan Li
    Guojin Wang
    Jia Song
    Erbao Ruan
    Huaquan Wang
    Yuhong Wu
    Xiaoming Wang
    Kai Ding
    Zonghong Shao
    Clinical Drug Investigation, 2017, 37 : 167 - 174
12345